Advertisement

Anesthesia

The FDA released a safety communication for the drug Zofran, which could pre-dispose patients to develop a potentially fatal heart rhythm known as Torsades de Pointes, according to the American Society of Anesthesiologists.

The American Society of Anesthesiologists named Paul Pomerantz as its new chief executive officer, beginning March 4, 2013.

Advertisement

Editor's note: This article by Tony Mira, president and CEO of Anesthesia Business Consultants, an anesthesia & pain management billing and practice management services company, originally appeared in Anesthesia Business Consultants eAlerts, a free electronic newsletter. Sign-up to receive this…

Advertisement